Terrenoire G
Centre de Sociologie de l'Ethique, Paris, France.
J Med Ethics. 1992 Jun;18(2):79-85. doi: 10.1136/jme.18.2.79.
What ethical justification can be found for informing a person that he or she will later develop a lethal disease for which no therapy is available? This question has been discussed during the past twenty years by specialists concerned with the prevention of Huntington's Disease, an incurable late-onset hereditary disorder. Many of them have played an active role in developing experimental testing programmes for at-risk persons. This paper is based on a corpus of 119 articles; it reviews the development of their reflection and includes an outline of the ethical problems identified and the solutions adopted in pre-clinical protocols. Seen in a broader perspective, the experience of presymptomatic testing for Huntington's Disease has given medical geneticists the opportunity to clarify their ethical position in the as yet little explored field of predictive medicine.
告知一个人他或她日后会患上一种无药可治的致命疾病,能找到怎样的伦理依据呢?在过去二十年里,关注亨廷顿氏病(一种无法治愈的迟发性遗传性疾病)预防的专家们一直在讨论这个问题。他们中的许多人在为高危人群制定实验检测项目方面发挥了积极作用。本文基于119篇文章的语料库;回顾了他们思考的发展过程,包括所识别的伦理问题概述以及临床前方案中采用的解决方案。从更广泛的角度来看,亨廷顿氏病症状前检测的经验让医学遗传学家有机会在预测医学这个尚未充分探索的领域中阐明他们的伦理立场。